Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis
CONCLUSION: Our model-based economic evaluation provides a retrospective assessment of COVID-19 vaccination during the first 16 months of the program in Canada and suggests that it was welfare-improving, considering the decreased hospitalizations and use of healthcare resources, deaths averted and lower morbidity from conditions such as PCC.PMID:38440772 | PMC:PMC10911688 | DOI:10.14745/ccdr.v49i06a03
Source: Can Commun Dis Rep - Category: Infectious Diseases Authors: Ashleigh R Tuite Victoria Ng Raphael Ximenes Alan Diener Ellen Rafferty Nicholas H Ogden Matthew Tunis Source Type: research
More News: Canada Health | Coronavirus | Covid Vaccine | COVID-19 | Epidemiology | Infectious Diseases | Pandemics | Vaccines